Detalles de la búsqueda
1.
A Phase 1 Study of mTORC1/2 Inhibitor BI 860585 as a Single Agent or with Exemestane or Paclitaxel in Patients with Advanced Solid Tumors.
Cancers (Basel)
; 12(6)2020 May 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-32486385
2.
Novel approaches for molecular targeted therapy of breast cancer: interfering with PI3K/AKT/mTOR signaling.
Curr Cancer Drug Targets
; 13(2): 188-204, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23215720
3.
Tremelimumab in combination with exemestane in patients with advanced breast cancer and treatment-associated modulation of inducible costimulator expression on patient T cells.
Clin Cancer Res
; 16(13): 3485-94, 2010 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20479064
Resultados
1 -
3
de 3
1
Próxima >
>>